Biotech slams ‘nonsense information’ about company prospects
MELBOURNE: The chair of billion-dollar biotech Clinuvel has used the company’s annual general meeting to
MELBOURNE: The chair of billion-dollar biotech Clinuvel has used the company’s annual general meeting to